Risk Assessment of Nanomaterials in a Regulatory Context

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The document examines the challenges of applying traditional risk assessment to manufactured nanomaterials, noting that their unique properties—such as high surface-area-to-volume ratios and ability to cross biological barriers—make existing 'bulk' chemical regulations ineffective. It highlights critical gaps in hazard and exposure data, the lack of standardised testing methods, and the limitations of alternative assessment methods like grouping, read-across, and nano-QSAR. The author concludes that robust risk assessments are currently impossible and urges regulatory bodies, particularly the European Commission, to adopt a precaution-based approach to protect human health and the environment.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Manufactured nanomaterials (MNM) possess specific properties that distinguish them from 'bulk' forms of the same substance, including a high surface-area-to-volume ratio and the ability to pass through biological barriers in humans and animals.
  • Existing regulatory frameworks and risk assessment tools are limited by significant knowledge gaps regarding the environmental and health impacts of nanomaterials, as well as a lack of standardised testing methods and agreed-upon terminology.
  • While the OECD suggests most 'bulk' chemical test guidelines are applicable to MNM, there is no scientific consensus on this, with some studies concluding that environmental fate cannot be reliably assessed using these guidelines.
  • Alternative risk assessment methods such as grouping, read-across, and nano-QSAR are being explored to avoid the resource-intensive process of case-by-case testing, but they currently lack the necessary high-quality data sets to be robust.
  • Grouping approaches for nanomaterials are currently premature and may introduce uncertainty, potentially leading to the over- or under-regulation of substances.
  • The European Commission is accused of delaying the implementation of existing legislation and the adoption of new rules for nanomaterials to avoid negatively impacting growth and competitiveness.

Cite the original document

APA
Center for International Environmental Law (2016). Risk Assessment of Nanomaterials in a Regulatory Context. https://www.ciel.org/wp-content/uploads/2016/12/NanoRiskAssessmentFactsheetFinal_6dec2016.pdf
Chicago
Center for International Environmental Law. Risk Assessment of Nanomaterials in a Regulatory Context. 2016. https://www.ciel.org/wp-content/uploads/2016/12/NanoRiskAssessmentFactsheetFinal_6dec2016.pdf.
Wikipedia
{{cite report |author=Center for International Environmental Law |title=Risk Assessment of Nanomaterials in a Regulatory Context |date=December 2016 |url=https://www.ciel.org/wp-content/uploads/2016/12/NanoRiskAssessmentFactsheetFinal_6dec2016.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{centerforinternationalenvironmentallaw2016risk, author = {{Center for International Environmental Law}}, title = {{Risk Assessment of Nanomaterials in a Regulatory Context}}, institution = {Center for International Environmental Law}, year = {2016}, month = dec, url = {https://www.ciel.org/wp-content/uploads/2016/12/NanoRiskAssessmentFactsheetFinal_6dec2016.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated